Menopausal hormone therapy use among active duty service women
The prevalence of HT use among ADSW ages 45 to 65 is lower than HT use among the US veteran population age 45 and older but higher than among the US general population age 45 and older.
Authors
- Miranda Lynn Janvrin (ORCID: https://orcid.org/0000-0002-3083-5581)
- Tracey Pérez Koehlmoos (ORCID: https://orcid.org/0000-0003-1377-8615)
- Katerina Shvartsman (ORCID: https://orcid.org/0009-0006-9692-9384)
- Jill Brown (ORCID: https://orcid.org/0000-0003-1615-4584)
- Amanda Banaag
Institutions
- Henry M. Jackson Foundation (US)
- Uniformed Services University of the Health Sciences (US)
- ORCID (US)
Publication Details
- Journal
- Menopause The Journal of The North American Menopause Society
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1097/gme.0000000000002469
- Citations
- 2
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- U.S. Department of Defense
- Henry M. Jackson Foundation
- National Board of Medical Examiners
- Uniformed Services University of the Health Sciences
- Department of Obstetrics and Gynecology, University of Wisconsin-Madison
- Defense Health Agency